The Science Behind TA-65® and Healthy Aging

Explore published research on telomeres lenghth, skin firming, Enhancing immune functions, Eye health improvement, Cardio-vascular conditions enhancements, and Anti-inflammation effect to discover the science behind TA-65®.

TA-65 increases short telomers's lenghth

A clinical study published in Rejuvenation Research examined the effects of TA-65 supplementation on telomere length over a 12-month period in 97 men and women aged 53–87.

The study reported that participants receiving TA-65 at a dose of 250 units experienced an average increase in telomere length, while participants in the placebo group experienced a length decrease.

These clinical findings demonstrate a difference in telomere-length changes between the TA-65 and placebo groups over the study period, providing scientific evidence of TA-65's effect on telomere length that plays a key role in cellular aging.

Study Link
Banner

TA-65 Capsules Stimulates Collagen & Elastin Production for Firmer, Tighter, More Elastic, Youthful-Looking Skin

A 16-week study involving 35 women at The Stern Center for Aesthetic Surgery (Bellevue, WA) found that daily use of TA-65 Cream was associated with multiple skin benefits:

  • Fewer Breakouts: Significantly reduced the average severity of skin breakouts after 8 weeks.
  • More Even Skin Tone: Significantly improved uneven pigmentation after 8 weeks, with further improvement after 16 weeks.
  • Reduced Signs of Inflammation: Helped reduce inflammation associated with premature skin aging after 16 weeks.
  • Collagen Support: Showed benefits associated with collagen production after 16 weeks.
  • Improved Skin Elasticity: Supported skin integrity by increasing elastin.
Study Link
Banner

TA-65: Supporting Immune Functions and Healthy Aging

A nine-month study published in OBM Geriatrics in April 2021 investigated the effects of TA-65 supplementation in 500 men and women aged 45–75, using daily doses ranging from 100 to 500 units.

Key study findings:

  • Supports Immune Cell Function: TA-65 was associated with changes in specific immune cell populations linked to age-related immune decline.
  • Positive Changes in T-Cell Markers: The study reported an improvement of 28 cells per microliter of blood in the measured CD8⁺CD28⁻ T-cell population.
  • Investigating Telomere-Related Aging: The findings contribute to research into how telomere shortening may affect immune cell function as we age.
Study Link
Banner

TA-65: Supporting Retinal Health and Helping Preserve Vision as You Age

A 12-month study involving 38 men and women aged 52–83 with age-related macular degeneration (AMD), published in the Journal of Clinical Ophthalmology in 2016, investigated the effects of TA-65 supplementation at 500 units per day.

Key study findings:

  • Improved Retinal Sensitivity: Participants taking TA-65 showed a statistically significant improvement in retinal sensitivity to light (p = 0.04).
  • Positive Vision Outcomes: The TA-65 group demonstrated improvements in visual function, while the placebo group experienced a decline over the study period.
  • Support for Age-Related Eye Health: The findings suggest that TA-65 may warrant further research into its potential role in supporting retinal function as we age.
Study Link
Banner

TA-65 reduces inflammation by 62% 

Newcastle, UK | June 21, 2023 

A clinical study published in GeroScience examined oral
TA-65, a telomerase activator, in older adults over 12 months,
participants receiving TA-65 showed lower systemic inflammation and
increased circulating lymphocyte counts compared with placebo.

1. Reduced Inflammation

62% lower hsCRP at 12 months. High-sensitivity C-reactive protein (hsCRP) is a blood marker associated with systemic inflammation. The lower levels observed in the TA-65 group suggest a reduction in this inflammatory marker.

2. Increased Immune Cell Counts

+285 lymphocytes/µL versus placebo. The TA-65 group showed a greater increase in total lymphocyte counts. These white blood cells play an important role in the body's
immune response.

Study Link
Banner

TA-65: Supporting Cardiovascular Health, and Healthy Cholesterol Levels

A 2018 study published in Current Pharmaceutical Design examined the potential protective effects of daily TA-65 supplementation on cardiovascular disease risk factors associated with metabolic syndrome. The study in one line: 37 adults with metabolic syndrome took TA-65 for 12 weeks and a placebo for 12 weeks.

What was better on TA-65 than on placebo: “Good” cholesterol (HDL) was
higher: about 7% more.

The LDL/HDL ratio was lower: about 12% less. This ratio is a marker of heart-disease risk.

Body measures were lower: BMI was less and waist was 0.9 cm smaller.

An inflammation marker (TNF-α) was lower: about 14% less.

The changes were linked: people whose HDL rose more also had bigger drops in inflammation markers.

Study Link
Banner

TA-65 Cream

Clinical Study Results

TA-65 Cream improves skin firmness by 89% in 3 months

A 12-week study of 54 women conducted at Essex Testing Clinic Inc. (Verona, NJ) found that daily use of TA-65 Cream improved skin firmness by 42% after 2 weeks and 89% after 12 weeks.

  • Younger-looking skin: almost 90% of participants strongly agreed their skin looked healthier and more youthful.
  • Improved skin appearance: Helped improve uneven pigmentation and the appearance of dark spots.
  • Gentle on skin: No irritation was reported throughout the study.
Study Link
Banner
تمت إضافة المنتج بنجاح إلى عربة التسوق الخاصة بك
مواصلة التسوق عرض عربة التسوق